Introduction {#s01}
============

Endocytosis is a fundamental biological process. In contrast to clathrin-dependent endocytosis, clathrin-independent endocytosis does not require dynamin ([@bib29]). The cargo proteins that come into the cell via clathrin-independent endocytosis will enter early endosomes, where the cargo is sorted and delivered to different destinations. The small GTPase Arf6 is implicated in the recycling and trafficking of clathrin-independent cargo. Its functionality is closely associated with phosphoinositide phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) metabolism ([@bib23]).

Arf6 activity is managed by guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs). In the human genome, 15 Arf-GEFs are encoded, of which eight are classified as Arf6-GEFs and belong to three families: cytohesin, EFA6, and BRAG ([@bib8]). Previous studies showed that different Arf6-GEFs could be activated by distinct mechanisms and thus participate in various functional processes ([@bib35]). The cytohesin family members Cytohesin1, ARNO, and Grp1 do not exclusively manage Arf6 ([@bib8]), whereas the EFA6 family proteins specifically catalyze the nucleotide exchange of Arf6 ([@bib27]; [@bib20]; [@bib54]; [@bib75]). Studies on BRAG family members demonstrated that the GEF activity of GEP100 is specific to Arf6, and GEP100 partially colocalizes with Arf6 on endosomes ([@bib86]; [@bib26]; [@bib34]).

PI(4,5)P2 mainly resides in the plasma membrane ([@bib19]), and its synthetic precursor, phosphatidylinositol 4-phosphate (PI(4)P), is primarily derived from the Golgi apparatus and the plasma membrane ([@bib22]). PI(4,5)P2 contributes to endocytosis by recruiting proteins such as AP-2, epsin, and dynamin, and it is rapidly degraded after endocytosis ([@bib57]). Arf6 also localizes in the plasma membrane but does not seem to regulate clathrin-dependent endocytosis. In contrast, Arf6 inactivation is vital for cargo sorting after endocytosis ([@bib23]). The constitutively activated Arf6 continuously activates phosphatidylinositol-4-phosphate 5 kinase (PIP5 kinase), producing unusually high amounts of endosomal PI(4,5)P2 and disrupting the sorting and subsequent recycling transport ([@bib7]; [@bib62]). In *Caenorhabditis elegans*, RAB-10 can recruit CNT-1/ARF-6-GAP to endosomes, shutting down ARF-6 activity. In the absence of RAB-10, the level of PI(4,5)P2 was significantly increased, and the recycling of clathrin-independent cargo hTAC-GFP was severely affected ([@bib83]). Arf6 is also involved in the regulation of actin cytoskeleton, and the overexpression of dominant-negative mutant Arf6(T27N) inhibited a series of actin-related processes, including cell spreading and wound healing ([@bib87]; [@bib71]; [@bib5]; [@bib67]; [@bib76]). The regulatory effects of Arf6 on actin can also be mediated by PI(4,5)P2, which recruits actin regulators to influence actin dynamics ([@bib97]).

Phosphoinositide phosphatase Sac1p was first identified in the study of suppressors of actin mutant alleles in yeast ([@bib66]). Accumulating evidence indicates that Sac1p homologues are associated with various biological processes, including affecting cell shape changes in the amnioserosa and JNK signaling during dorsal closure in *Drosophila melanogaster* ([@bib94]). Sac1p contains an N-terminal SAC domain and two C-terminal transmembrane helices ([@bib46]; [@bib36]). The SAC domains of Sac1p and its homologues have the specificity of hydrolyzing PI(3)P, PI(4)P, and PI(3,5)P2 ([@bib31]; [@bib39]; [@bib63]; [@bib16]; [@bib22]; [@bib91]). The SAC domain contains seven conserved motifs, and the consensus sequence RXNCXDCLDRTN in the sixth motif is the phosphatase catalytic core ([@bib38]). Mutations of the three amino acid sites (D394, A445, and R483) within the catalytic core efficiently disrupted the enzymatic activity ([@bib44]; [@bib73]; [@bib52]). The SAC domain also contributes to protein interactions. A catalytically inactive mutant of hSAC1 is not capable of interacting with the COPI complex ([@bib74]). Likewise, in *C. elegans*, the SAC domain of UNC-26/synaptojanin is required for the targeting of UNC-26 to synapses ([@bib25]). Sac1p/hSAC1 resides in the ER and Golgi and shuttles between ER and Golgi via COPI and COPII ([@bib45]; [@bib74]; [@bib4]; [@bib2]; [@bib16]). The distribution of hSAC1 on the Golgi is directed by the first transmembrane helix and the N-terminal cytoplasmic region ([@bib92]). It has also been reported that hSAC1 intracellular localization can be directed by additional proteins. For example, in mammalian neurons, palmitoylated JNK3 was found to recruit hSAC1 to the Golgi, thereby down-regulating the abundance of PI(4)P and post-Golgi trafficking ([@bib96]).

The *C. elegans* genome encodes two yeast Sac1p homologues, F30A10.6/SAC-1 and W09C5.7/SAC-2, homologous to mammalian SAC1 and SAC2, respectively. To gain insight into the mechanism by which ARF-6 functions in recycling transport, we conducted an ARF-6 interactor screen and identified SAC-1 as a novel binding protein. SAC-1 is widely expressed in a variety of tissues, including the intestine, pharynx, pharyngeal neurons, and spermatheca ([@bib47]). In *C. elegans* intestinal cells, we observed that SAC-1 maintains significant colocalization with ARF-6. In the absence of ARF-6, the subcellular distribution of GFP-SAC-1 was significantly affected. In particular, we noted that SAC-1 acts to ensure proper apical secretory delivery and basolateral recycling transport. Further analysis revealed that in *sac-1* mutants, PI(4,5)P2 levels significantly increased and the ARF-6 effector UNC-16 accumulated in the cytosol, suggesting that SAC-1 down-regulates ARF-6 activity. As expected, we found that SAC-1 competes with ARF-6(T27N) for binding to BRIS-1/ARF-6-GEF in a concentration-dependent manner. Depletion of SAC-1 led to the significant increase of the overlap between ARF-6-GFP and BRIS-1-mCherry. Our observations indicate that SAC-1, as a novel interactor of ARF-6, exerts an adverse effect on ARF-6 activation by interfering in the interaction between inactive ARF-6(GDP) and the GEF protein BRIS-1.

Results {#s02}
=======

SAC-1 interacts with both active and inactive ARF-6 {#s03}
---------------------------------------------------

Arf6 is predominantly localized in the plasma membrane, and Arf6 needs to be inactivated after endocytosis for appropriate cargo sorting in endosomes ([@bib23]). Overexpression of Arf6(Q67L), the constitutively active mutant form of Arf6, induces the persistent activity of PIP5 kinase. This leads to an unusually high amount of PI(4,5)P2 in the endosomal membrane, thereby impairing clathrin-independent cargo sorting and recycling ([@bib7]; [@bib62]). Our previous study showed that *rab-10* mutant is superficially normal in growth and development ([@bib82]; [@bib93]). In particular, *rab-10* mutants overaccumulate hTAC-GFP in enlarged structures in the deep cytosol of intestinal epithelia ([@bib11]). Thus, we performed a genome-wide RNAi screen using *rab-10(RNAi)* as the positive control to identify candidate genes whose expression knockdown lead to the hTAC-GFP overaccumulation in the intestine. After initial screen and the follow up validation, we noted that RNAi-mediated knockdown of 54 candidates resulted in intracellular hTAC-GFP aggregation, including SAC-1, ARX-7, GGTB-1, EXOC-7, HUM-2, and SEC-10. The previous study in mammal showed that HUM-2/myosin functions with Rab10 to mediate the delivery of GLUT4 storage vesicles to the plasma membrane ([@bib13]). Recently, SEC-10 and EXOC-7 were found to be involved in the regulation of hTAC recycling in *C. elegans* intestine ([@bib12]). We then conducted a small-scale screen for potential ARF-6(Q67L) interacting partner via GST pull-down assays. Out of 54 candidates, SAC-1 is the only one that exhibits a significant interaction with ARF-6(Q67L). Remarkably, SAC-1 interacts with ARF-6(Q67L) via its SAC domain with notable specificity ([Fig. 1 A](#fig1){ref-type="fig"} and Fig. S1, A and B). Also, we observed a moderate binding of SAC-1 to the GDP-bound mutant form ARF-6(T27N) ([Fig. 1 A](#fig1){ref-type="fig"}). We further performed coimmunoprecipitation experiments and validated the interaction of SAC-1 with ARF-6(Q67L) and ARF-6(T27N) (Fig. S1 C). Arf1 is predominantly an ER- and Golgi-associated small GTPase ([@bib24]). In addition, Arf1 was reported to function at the plasma membrane to modulate the cortical actin ([@bib10]). To determine whether SAC-1 binds to ARF-1.2/Arf1, we examined the interaction of GST-SAC-1 with HA-ARF-1.2(Q71L) or HA-ARF-1.2(T31N). Nevertheless, both active and inactive mutant forms of ARF-1.2 failed to interact with SAC-1 (Fig. S1 D). We also selected the constitutively active mutant form of endocytic trafficking--related Rabs for the GST pull-down assay. Our results indicate that there was no significant binding between GST-SAC-1 and HA-tagged RAB-5(Q78L), RAB-7(Q68L), RAB-8(Q67L), RAB-10(Q68L), and RAB-11(Q70L), respectively ([Fig. 1 A](#fig1){ref-type="fig"}).

![**SAC-1 interacts with the active and inactive mutant forms of ARF-6, and the residence of SAC-1 in basolateral puncta requires ARF-6. (A)** Western blot showing GST pull-down with in vitro--translated HA-tagged proteins. Glutathione beads loaded with GST and GST-SAC-1 were incubated with in vitro--expressed HA-tagged RAB-5(Q78L), RAB-7(Q68L), RAB-8(Q67L), RAB-10(Q68L), RAB-11(Q70L), ARF-6(Q67L), and ARF-6(T27N). Eluted proteins were separated on the SDS-PAGE gel and analyzed by Western blotting using anti--HA antibody. Input lanes contain in vitro--expressed HA-tagged proteins in the binding assays (5%). **(B and B′)** SAC-1 colocalized well with ARF-6--, RAB-5--, or RAB-10--labeled endosomes. In addition, SAC-1 overlaps significantly with the TGN marker AMAN-2 and the ER marker SP12. Nevertheless, SAC-1 displayed little colocalization with the late endosome marker RAB-7. Arrowheads indicate positive overlap. Pearson's correlation coefficients for GFP and mCherry signals were calculated (*n* = 6 animals). **(C and C′)** Compared with wild-type animals, the labeling of GFP-SAC-1 in basolateral puncta was significantly reduced in the absence of ARF-6 (top focal plane). Transgenic expression of ARF-6(Q67L)-mCherry rescued the puncta labeling GFP-SAC-1, and the transgenic expression of ARF-6(T27N)-mCherry failed to restore the endosomal localization of GFP-SAC-1. Asterisks in the panels indicate intestinal lumen. Error bars represent SEM (*n* = 18 each), and asterisks indicate the significant differences in the one-tailed Student's *t* test (ns, no significance; \*\*, P \< 0.01; \*\*\*, P \< 0.001). Bars, 10 µm.](JCB_201711065_Fig1){#fig1}

To define the subcellular localization of SAC-1, we performed colocalization assays in intestinal cells. In wild-type animals, mCherry-SAC-1 labels ER-like structures in the deep cytosol and punctate structures near the basolateral plasma membrane, and GFP-tagged ARF-6 resides in basolateral tubules and puncta ([@bib83]; [@bib28]). We observed that mCherry-SAC-1 and ARF-6-GFP had significant colocalization in basolateral puncta ([Fig. 1, B and B](#fig1){ref-type="fig"}′; Pearson's correlation coefficient, ∼73.8%). RAB-5/Rab5 is a marker of early endosomes ([@bib64]; [@bib11]; [@bib60]). We compared the localization of SAC-1 with RAB-5 and observed that mCherry-SAC-1 overlapped well with GFP-RAB-5 on endosomal structures ([Fig. 1, B and B](#fig1){ref-type="fig"}′; Pearson's correlation coefficient, ∼67%). Previous studies showed that recycling regulator RAB-10 partially colocalizes with RAB-5 on early endosomes, where it appears to promote the maturation of early endosomes to recycling endosomes ([@bib11]; [@bib82]). In our study, SAC-1 and RAB-10 had significant overlap in cytosolic punctate structures ([Fig. 1, B and B](#fig1){ref-type="fig"}′; Pearson's correlation coefficient, ∼75.8%). We also compared the localization of SAC-1 with other endosomal markers. SAC-1 failed to significantly overlap with the late endosome marker RAB-7 ([Fig. 1, B and B](#fig1){ref-type="fig"}′; Pearson's correlation coefficient, ∼24.4%). Sac1p/hSAC1 has been reported to reside in the ER and Golgi, where it participates in the regulation of PI(4)P pool ([@bib45]; [@bib4]; [@bib2]; [@bib16]). As expected, we observed a partial colocalization between SAC-1 and the TGN marker AMAN-2 ([Fig. 1, B and B](#fig1){ref-type="fig"}′; Pearson's correlation coefficient, ∼62%). There was extensive overlap between the ER marker SP12-GFP and mCherry-SAC-1 in patch-like structures ([Fig. 1, B and B](#fig1){ref-type="fig"}′; Pearson's correlation coefficient, ∼87%). It is also worth emphasizing that the mCherry-SAC-1--labeled basolateral puncta are independent of the SP12-GFP--positive structures.

Localization of SAC-1 in basolateral puncta requires the presence of ARF-6(GTP) {#s04}
-------------------------------------------------------------------------------

Small GTPases such as Arfs and Rabs usually recruit effectors to exert specific cellular effects ([@bib41]; [@bib15]). In the absence of a specific small GTPase, the intracellular localization or distribution of its effector is often compromised. For example, in *rab-10* mutants, the RAB-10 effectors CNT-1 and TBC-2 membrane association were impaired, showing cytoplasmic dispersion ([@bib83]; [@bib50]). To test whether the localization of SAC-1 is dependent on the presence of ARF-6, we prepared transgenic animals that specifically expressed GFP-SAC-1 in intestinal cells. In the wild-type background, GFP-SAC-1 mostly labels basolateral puncta and ER-like patch structures ([Fig. 1 C](#fig1){ref-type="fig"}). In *arf-6(tm1447)* mutants, the labeling of GFP-SAC-1 in basolateral puncta was significantly diminished ([Fig. 1, C and C](#fig1){ref-type="fig"}′; ∼60% intensity decrease). Instead, GFP-SAC-1--labeled patch-like structures in the deep cytosol were intact. We performed colocalization assays to dissect the observed localization variation of SAC-1. As expected, SAC-1 presented little overlap with RAB-10 in *arf-6(RNAi)* animals ([Fig. 1, B and B](#fig1){ref-type="fig"}′; and Fig. S1, E and E′). In contrast, the remaining SAC-1--positive puncta still colocalized with AMAN-2-GFP foci ([Fig. 1, B and B](#fig1){ref-type="fig"}′; and Fig. S1, E and E′), suggesting that ARF-6 is not involved in the Golgi positioning of SAC-1. Also, the overlap between mCherry-SAC-1 and ER marker SP12-GFP was not affected in the absence of ARF-6 ([Fig. 1, B and B](#fig1){ref-type="fig"}′; and Fig. S1, E and E′). These results suggest that the residence of SAC-1 in basolateral endosomes requires the presence of ARF-6, and the Golgi and ER positioning mechanisms of SAC-1 are distinct from that in endosomes.

SAC-1 is a transmembrane protein ([@bib46]; [@bib36]), and the potential explanation for our results is that ARF-6 is responsible for clustering SAC-1 from connected membranous organelles to the sorting endosomes. We then performed rescue experiments by coexpressing ARF-6(Q67L)-mCherry or ARF-6(T27N)-mCherry in *arf-6(tm1447)* animals ([Fig. 1, C and C](#fig1){ref-type="fig"}′). Interestingly, the transgenic expression of ARF-6(Q67L) significantly recuperated the puncta labeling GFP-SAC-1, whereas the expression of ARF-6(T27N) failed to restore the endosomal localization of GFP-SAC-1 ([Fig. 1, C and C](#fig1){ref-type="fig"}′).

To determine whether the endosomal localization of SAC-1 requires the presence of ARF-1.2, we examined the GFP-SAC-1 distribution in *arf-1.2(RNAi)* animals. GFP-SAC-1 appeared in the enlarged structures upon loss of ARF-1.2 (Fig. S1, F and F′). Moreover, there was substantial colocalization between Golgi marker AMAN-2-GFP and mCherry-SAC-1 in those enlarged structures (Fig. S1, G and G′). Together with the biochemical data (Fig. S1 D), these observations suggested that ARF-1.2, although not directly interacting with SAC-1, is required for the secretory delivery of SAC-1 in intestinal cells.

Clathrin-independent recycling cargo hTAC-GFP is trapped in early endosomes in *sac-1* mutants {#s05}
----------------------------------------------------------------------------------------------

ARF-6/Arf6 is essential for the basolateral recycling flow of clathrin-independent cargo ([@bib23]; [@bib83]). Our finding that SAC-1 is an ARF-6 interactor prompted us to determine whether SAC-1 is required for ARF-6--mediated recycling transport in vivo. We sought to examine the steady-state distribution of the well-established clathrin-independent cargo hTAC-GFP (human IL-2 receptor α-chain) and clathrin-dependent cargo hTfR-GFP (human transferrin receptor; [@bib11]; [@bib83]). We developed a transgenic strain *sac-1(ycx18)*, an intestine-specific CRISPR/Cas9 somatic mutant ([Fig. 2 A](#fig2){ref-type="fig"} and Table S2; [@bib48]). Live-cell imaging revealed that hTAC-GFP overaccumulated in intracellular aggregates upon loss of SAC-1 ([Fig. 2, A](#fig2){ref-type="fig"} and A′). Normally, hTAC-GFP predominantly coexists with recycling endosome marker EHBP-1, and to a lesser extent, early endosome marker EEA-1-2xFYVE ([@bib93]; [Fig. 2, B and B](#fig2){ref-type="fig"}′). In the absence of SAC-1, the localization of hTAC-GFP in recycling endosomes was reduced, and the localization in 2xFYVE-labeled early endosomes was significantly enhanced, indicating a blockage of early endosome to recycling endosome transport ([Fig. 2, B and B](#fig2){ref-type="fig"}′). It is also worth noting that hTfR-GFP accumulated in intracellular structures in *sac-1* mutants (Fig. S1, H and H\'). A nonrecycling cargo, GFP-CD4-LL, showed a similar cytosolic distribution abnormality (Fig. S1, I and I′).

![**The recycling transport of hTAC-GFP is impaired in *sac-1* mutants. (A and A′)** In the top focal plane, IL-2 receptor α chain hTAC-GFP--labeled tubular structures were severely perturbed in *sac-1(ycx18)* mutants. In the middle focal plane, hTAC-GFP overaccumulated on the cytosolic endosomal structures. An approximately 5.4-fold escalation of total hTAC-GFP intensity was observed in *sac-1* animals. Also, in mCherry-SAC-1--overexpressing intestinal cells, hTAC-GFP accumulated on the enlarged structures. RNAi-mediated knockdown of PPK-1 failed to alleviate the overaccumulation phenotype of hTAC-GFP in *sac-1(ycx18)* mutants. Asterisks in the panels indicate intestinal lumen. Error bars represent SEM (*n* = 18 each), and asterisks indicate significant differences in the one-tailed Student's *t* test (\*\*\*, P \< 0.001). **(B and B′)** The subcellular localization of the accumulated hTAC-GFP in *sac-1(ycx18)* mutants. In the absence of SAC-1, the overlap between hTAC-GFP and EHBP-1-mCherry was reduced, whereas the colocalization between hTAC-GFP and mCherry-2xFYVE was increased. Arrowheads indicate positive overlap. Pearson's correlation coefficients for GFP and mCherry signals were calculated (*n* = 6 animals). Error bars represent SEM. \*\*\*, P \< 0.001. Bars, 10 µm.](JCB_201711065_Fig2){#fig2}

A recent study showed that the SAC domain protein SAC2 localizes at early endosomes and recycling endosomes in mouse N2A cells. Overexpression of the catalytically inactive mutant of SAC2 disrupts TfR (Transferrin receptor) recycling ([@bib37]). We then examined whether the recycling transport of hTAC-GFP was affected in *sac-2(ok2743)* mutant cells. In vivo imaging results showed that the absence of SAC-2 had no significant effect on the steady-state distribution of hTAC-GFP (Fig. S1, J and J′).

SAC-1 depletion exclusively impairs apical secretory transport in intestinal epithelia {#s06}
--------------------------------------------------------------------------------------

Sac1p/hSAC1 is implicated in the secretory transport via modulating actin and lipid metabolism ([@bib17]; [@bib95]; [@bib44]; [@bib39]; [@bib79]; [@bib22]). To determine whether SAC-1 acts to regulate secretory transport in intestinal epithelia, we used two different types of Golgi apparatus derived secretory cargo proteins: NPY-GFP (neuropeptide Y) and PGP-1-GFP (ATP-binding cassette transporter; [@bib61]; [@bib77]). Neuropeptide Y fusion proteins have been proven to be secretory cargo in PC12 and HeLa cells ([@bib61]; [@bib3]; [@bib84]). In *C. elegans* intestinal epithelia, we observed that NPY-GFP localizes mainly in the basolateral meshwork (top focal plane), lacking apparent apical membrane labeling (Fig. S2, A and A′). The absence of exocyst component SEC-6 resulted in NPY-GFP overaccumulation in cytosolic structures, and the labeling of NPY-GFP in basolateral tubules decreased, indicating a secretory defect (Fig. S2, A and A′). RAB-8/Rab8 is specifically required for the proper delivery of apical secretory cargo in *C. elegans* and mammalian intestinal epithelia ([@bib77]; [@bib84]). In *rab-8* mutants, we failed to detect the distribution abnormality of NPY-1-GFP, suggesting that NPY-GFP is delivered with basolateral directionality (Fig. S2, A and A′). There was no irregularity of NPY-GFP transport in SAC-1--depleted cells (Fig. S2, A and A′). However, we noticed that apical secretory cargo PGP-1-GFP significantly accumulated in intracellular aggregates in *sac-1(ycx18)* mutants (Fig. S2, B and B′), in a manner very similar to *rab-8* mutants (Fig. S2, B and B′). Our results suggest that SAC-1 functions specifically to promote apical secretory transport without affecting the basolateral secretion in the intestinal epithelia of *C. elegans*.

Moreover, we observed that the labeling levels of TGN marker AMAN-2-GFP moderately decreased (Fig. S2, C--C″). This phenotypical change could be associated with the PGP-1-GFP secretion defects. There were no noticeable changes in the patterns of AMAN-2-GFP or SP12-GFP labeled ER upon loss of SAC-1, suggesting that the detrimental effect of SAC-1 depletion on apical secretion does not disrupt the morphology or distribution of the Golgi and ER (Fig. S2, C--D′).

Loss of SAC-1 leads to significantly elevated PI(4,5)P2 levels in endosomes {#s07}
---------------------------------------------------------------------------

The SAC homologue domain has phosphoinositide phosphatase specificities to PI(3)P, PI(4)P, and PI(3,5)P2 ([@bib31]; [@bib39]; [@bib63]; [@bib91]). Specifically, the SAC domain of yeast Sac1p and its homologues participate in the modulation of intracellular PI(4)P pool ([@bib52]; [@bib14]; [@bib22]). Arf6/ARF-6 was reported to up-regulate intracellular PI(4,5)P2 levels by activating downstream PIP5 kinase ([@bib7]; [@bib62]; [@bib83]). To clarify whether SAC-1, as an ARF-6 interactor, manipulates endosomal P(4,5)P2 in intestinal cells, we used a newly developed PI(4,5)P2 biosensor, Tb^R332H^-GFP, to examine the intracellular levels of PI(4,5)P2 in *sac-1* mutant animals ([@bib70]; [@bib33]). As expected, in *C. elegans* intestinal cells, Tb^R332H^-mCherry colocalizes extensively with the canonical PI(4,5)P2 biosensor PH-GFP (Fig. S3, A and A′; Pearson's correlation coefficient, ∼92.7%). We also assayed the distribution of the PI(3)P marker GFP-2xFYVE, the PI(4)P marker GFP-P4M, and the PI(3,5)P2 marker GFP-2xML1N, respectively ([@bib49]; [@bib32]; [@bib93]). In the absence of SAC-1, Tb^R332H^-GFP overaccumulated on the intracellular aggregates and tubules ([Fig. 3, A](#fig3){ref-type="fig"} and A\', ∼3.29-fold intensity increase). The PH-GFP--labeled structures also accumulated in *sac-1(ycx18)* mutant cells (Fig. S3, B and B′; ∼3.37-fold intensity increase). To determine the endosomal identity of Tb^R332H^-GFP aggregates, we compared the overlap between the early endosome marker mCherry-RAB-5 and Tb^R332H^-GFP. Although the colocalization level between the tubular Tb^R332H^-GFP and the punctate mCherry-RAB-5 is apparently low in the wild-type background, Tb^R332H^-GFP significantly overlapped with mCherry-RAB-5 in the enlarged endosomes upon loss of SAC-1 ([Fig. 3, B and B](#fig3){ref-type="fig"}′). In agreement with the perturbed localization of hTAC-GFP in *sac-1(RNAi)* animals, this finding indicates that Tb^R332H^-GFP usually labels recycling endosomes (Fig. S3, C and C′), and the loss of SAC-1 affects phosphoinositides (PIPs) homeostasis, which in turn causes PI(4,5)P2 to accrue abnormally in early endosomes ([Fig. 3, B and B](#fig3){ref-type="fig"}′). Together, these results suggest that SAC-1 is a negative regulator of PI(4,5)P2 abundance in endosomes.

![**Loss of SAC-1 leads to increased PI(4,5)P2 levels and overaccumulation of actin structures. (A and A′)** Compared with wild-type animals, the labeling intensity of Tb^R332H^-GFP in the basolateral endosomes was significantly increased (by ∼3.3-fold) in *sac-1(ycx18)* mutants. However, in mCherry-SAC-1--overexpressing intestinal cells, Tb^R332H^-GFP labeling in puncta and tubules decreased remarkably. Furthermore, RNAi-mediated knockdown of PPK-1 (PIP5 kinase) significantly reversed the intensity of Tb^R332H^-GFP in *sac-1* mutants. Error bars represent SEM (*n* = 18 each), and asterisks indicate significant differences in the one-tailed Student's *t* test (\*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001). **(A″)** Western blot showing the PPK-1-GFP level in animals before and after the RNAi-mediated PPK-1 knockdown. **(B and B′)** The colocalization level between Tb^R332H^-GFP and mCherry-RAB-5 is relatively low in wild-type animals. Tb^R332H^-GFP overlapped with mCherry-RAB-5 in the enlarged early endosomes in *sac-1(RNAi)* animals. Arrowheads indicate positive overlap. Pearson's correlation coefficients for GFP and mCherry signals were calculated (*n* = 6 animals). Error bars represent SEM. \*\*\*, P \< 0.001. **(C and C′)** In *sac-1(ycx18)* mutants, the intensity of GFP-Utrophin-CH-labeled actin structures was extensively up-regulated (by ∼6.1-fold). Error bars represent SEM (*n* = 18 each), and asterisks indicate significant differences in the one-tailed Student's *t* test (\*\*\*, P \< 0.001). **(D and D′)** In wild-type animals, GFP-RME-1 labeled basolateral recycling endosomes, showing the tubular and punctate distribution (top focal plane). However, the basolateral meshwork labeled by GFP-RME-1 was greatly disrupted in *sac-1(ycx18)* mutants. GFP-RME-1--positive structures accumulated in the cytoplasmic puncta (middle focal plane). Asterisks in the panels indicate intestinal lumen. Error bars represent SEM (*n* = 18 each). Asterisks indicate significant differences in the one-tailed Student's *t* test (\*\*\*, P \< 0.001). **(E and E′)** Compared with wild-type animals, loss of SAC-1 resulted in an accumulation of RAB-10--labeled puncta. Error bars represent SEM (*n* = 18 each), and asterisks indicate significant differences in the one-tailed Student's *t* test (\*\*\*, P \< 0.001). Bars, 10 µm.](JCB_201711065_Fig3){#fig3}

We also noted that the labeling intensity of GFP-2xFYVE--labeled puncta increased significantly (Fig. S3, D and D′). Consistent with the up-regulation of PI(3)P, GFP-RAB-5--labeled early endosomes accumulated in large quantities upon loss of SAC-1 (Fig. S4, C and C′). PI(3)P is required for cargo sorting and transport regulation in early endosomes ([@bib65]; [@bib85]; [@bib68]; [@bib37]). The accumulation of hTfR-GFP correlates with the significant PI(3)P buildup in SAC-1--deficient cells, suggesting that this phenotype is independent of the PI(4,5)P2 hike in *sac-1* mutants. Consistent with this hypothesis, the accumulation of hTfR-GFP was not mitigated in *sac-1(ycx18);ppk-1(RNAi)* animals (Fig. S1, H and H′). Various studies indicated that the SAC domain of Sac1p has the specificity of hydrolyzing PI(4)P and PI(3,5)P2 ([@bib31]; [@bib39]; [@bib63]; [@bib16]; [@bib22]; [@bib91]). However, the PI(4)P marker GFP-P4M or the PI(3,5)P2 marker GFP-2xML1N had no significant changes in distribution or intensity in the absence of SAC-1 (Fig. S3, E--F′). Consistently, although SAC-1 localizes in TGN, we did not observe any noteworthy abnormalities of AMAN-2-GFP subcellular distribution in *sac-1* mutants (Fig. S2, C--C″). To clarify whether ER- and Golgi-located SAC-1 was efficiently depleted in *sac-1(ycx18)* mutants, we conducted colocalization experiment to determine the colabeling of the TGN marker AMAN-2 or the ER marker SP12 with SAC-1 in *sac-1(ycx18)* animals. The results showed that SAC-1 has a significant colocalization with AMAN-2 or SP12 in wild-type animals ([Fig. 1, B and B](#fig1){ref-type="fig"}′). However, in the absence of SAC-1, these significant overlaps were severely disrupted because of the lack of the CRISPR/Cas9 editing--sensitive mCherry-SAC-1 labeling (Fig. S3, G and G′). These findings suggest that, at least in *C. elegans* intestinal cells, Golgi- and ER-located SAC-1 is not the sole regulator of PI(4)P pool, and additional mechanisms are underlying the metabolism of PI(4)P in the Golgi and ER. Given these findings, we further examined the colocalization of mCherry-SAC-1 with Tb^R332H^-GFP or GFP-2xFYVE. mCherry-SAC-1 and Tb^R332H^-GFP exhibited a significant colocalization in intracellular puncta (Fig. S3, H and H′; Pearson's correlation coefficient, ∼72%). mCherry-SAC-1 also partially overlapped with GFP-2xFYVE on punctate structures in the cytosol (Fig. S3, H and H′; Pearson's correlation coefficient, ∼58%).

In agreement with the escalation of Tb^R332H^-GFP labeling, the intensity of PI(4,5)P2 immunostaining significantly increased in *sac-1* mutants (Fig. S3, I and I′). The absence of SAC-1--induced PI(4,5)P2 up-regulation appears to be correlated with the alteration in the total level of PIPs, which moderately increased upon loss of SAC-1 (Fig. S3, J and J′). PI(4,5)P2 synthetic precursor PI(4)P is mainly derived from the Golgi and plasma membrane ([@bib22]). However, the overall intensity of the PI(4)P marker GFP-P4M remains mostly unchanged in *sac-1* mutant cells (Fig. S3, E and E′). These data suggest that the prominent increase of PI(4,5)P2 is unlikely at the expense of a loss of the PI(4)P pool, and the increase in PI(4,5)P2 levels could justify the up-regulation of the total cellular PIPs. We validated the specificity of the intestine-specific CRISPR/Cas9 *sac-1(ycx18)* mutants by coexpressing a CRISPR/Cas9 editing--resistant form of mCherry-SAC-1 in the intestine. We found that the CRISPR/Cas9 editing--resistant transgene fully rescued the Tb^R332H^-GFP overaccumulation phenotype in *sac-1(ycx18)* mutants, where the Tb^R332H^-GFP intensity was even lower than those of wild-type animals (Fig. S3, K and K′). These results also indicate that the requirement for SAC-1 in PI(4,5)P2 modulation is cell autonomous.

PI(4,5)P2 is a crucial actin cytoskeleton regulator, affecting actin organization via actin-binding proteins ([@bib97]; [@bib93]). In wild-type animals, actin marker GFP-Utrophin-CH predominantly labels puncta- and strip-like structures within the cytoplasm. We observed that the overall intensity of GFP-Utrophin-CH-positive structures substantially increased in the *sac-1* mutant background ([Fig. 3, C and C](#fig3){ref-type="fig"}′; ∼6.1-fold increase). In the absence of SAC-1, ACT-5-GFP--labeled puncta also overaccumulated and formed cytosolic aggregates (Fig. S4, A and A′).

The functionality decay of ARF-6 underlies irregular PI(4,5)P2 abundance and hTAC-GFP recycling defects in SAC-1--depleted cells {#s08}
--------------------------------------------------------------------------------------------------------------------------------

The substantial increase of PI(4,5)P2 levels in *sac-1* mutants suggests that SAC-1 functions to attenuate ARF-6 activity. To test this possibility, we assessed the overall intensity of Tb^R332H^-GFP in mCherry-SAC-1--overexpressing intestinal cells. The Tb^R332H^-GFP labeling intensity in puncta and tubules decreased significantly (by ∼62.8%) compared with wild-type animals ([Fig. 3, A](#fig3){ref-type="fig"} and A′). Furthermore, RNAi-mediated knockdown of ARF-6 effector PPK-1/PIP5 kinase significantly alleviated the intensity boost of Tb^R332H^-GFP in *sac-1* mutants ([Fig. 3, A](#fig3){ref-type="fig"} and A′; intensity decreased by ∼93.5%).

Our previous studies indicated that the consistent inactivation of ARF-6 induced by the overexpression of ARF-6-GAP/CNT-1 led to a significant decrease in endosomal levels of PI(4,5)P2, which impaired the recycling of hTAC-GFP ([@bib83]). In the intestinal cells overexpressing mCherry-SAC-1, we observed that the overaccumulation phenotype of hTAC-GFP resembled that of CNT-1 overexpression cells ([Fig. 2, A](#fig2){ref-type="fig"} and A′; [@bib83]). The recycling defect of hTAC-GFP was not rescued in *sac-1(ycx18);ppk-1(RNAi)* animals ([Fig. 2, A](#fig2){ref-type="fig"} and A′). These experiments demonstrate that hTAC-GFP transport defects in SAC-1--depleted cells are closely associated with disturbed PI(4,5)P2 homeostasis ([@bib83]).

The level of PI(4,5)P2 is positively correlated with the membrane recruitment of the PI(4,5)P2-binding protein RME-1 ([@bib83]). As expected, in *sac-1* mutants, the GFP-RME-1--labeled meshwork collapsed, and GFP-RME-1 mislocalized and accumulated in cytosolic aggregates ([Fig. 3, D and D](#fig3){ref-type="fig"}′). These aggregated GFP-RME-1 overlapped well with early endosome marker mCherry-RAB-5 in the enlarged endosomal structures (Fig. S4, B and B′). Of note, PI(4,5)P2 accumulation in early endosomes could account for the aggregation of GFP-RME-1 in the perturbed membranous compartments ([Fig. 3, B and B](#fig3){ref-type="fig"}′). Furthermore, the irregular deposits of recycling regulator RME-1 could explain the defects in hTAC-GFP recycling in *sac-1* mutants. Previously, we reported that in *arf-6* or *cnt-1* mutants, the clathrin-independent cargo recycling regulator RAB-10 accumulated in intracellular endosomes, whereas distribution of the late endosomal marker RAB-7 was not affected ([@bib83]). Likewise, in *sac-1* mutants, RAB-10--labeled puncta overaccumulated in the cytoplasm ([Fig. 3, E and E](#fig3){ref-type="fig"}′), and the distribution of RAB-7--labeled structures was normal (Fig. S4, D and D′). Consistently, the RAB-10 effector EHBP-1--labeled tubular network was fully disrupted (Fig. S4, E and E′).

Loss of SAC-1 leads to intracellular accumulation of ARF-6 and UNC-16 {#s09}
---------------------------------------------------------------------

The precise regulation of endosomal PI(4,5)P2 is required for the proper flow of recycling transport. Irregular increase or decrease of PI(4,5)P2 levels will impair the recycling process. To further characterize the implication of SAC-1 in the recycling process, we assayed the subcellular distribution of ARF-6-GFP in *sac-1(ycx18)* animals ([Fig. 4, A](#fig4){ref-type="fig"} and A′). Loss of SAC-1 resulted in the accumulation of ARF-6-GFP in endosomal structures, and *sac-1(ycx18)* mutants displayed significantly reduced meshwork labeling of ARF-6-GFP, as expected if recycling transport is disrupted ([@bib83]). We conducted two sets of colocalization experiment to assess the labeling of the accumulated ARF-6. In wild-type animals, ARF-6 has a significant colocalization with the recycling endosome marker mCherry-RAB-10 in punctate structures and appears less localized in early endosome marker RAB-5--positive structures ([Fig. 4, B and B](#fig4){ref-type="fig"}′). SAC-1 depletion significantly increased the overlap between ARF-6 and RAB-5 in the enlarged endosomal structures, whereas the colocalization between ARF-6 and RAB-10 was significantly reduced ([Fig. 4, B and B](#fig4){ref-type="fig"}′).

![**Loss of SAC-1 leads to intracellular accumulation of ARF-6 and UNC-16 and HMP-1 mislocalization. (A and A′)** Depletion of SAC-1 resulted in the accumulation of ARF-6--labeled structures (by approximately twofold). Error bars represent SEM (*n* = 18 each). Asterisks indicate significant differences in the one-tailed Student's *t* test (\*\*\*, P \< 0.001). **(B and B′)** In *sac-1(RNAi)* animals, the overlap between ARF-6-GFP and mCherry-RAB-5 was enhanced. In *sac-1(RNAi)* animals, the colocalization between ARF-6-GFP and mCherry-RAB-10 was decreased. Arrowheads indicate positive overlap. Pearson's correlation coefficients for GFP and mCherry signals were calculated (*n* = 6 animals). Error bars represent SEM. \*\*\*, P \< 0.001. **(C and C′)** Loss of SAC-1 resulted in overaccumulation of UNC-16--labeled puncta (by approximately fourfold). Error bars represent SEM (*n* = 18 each). Asterisks indicate the significant difference in the one-tailed Student's *t* test (\*\*\*, P \< 0.001). **(D and D′)** In wild-type animals, HMP-1-GFP is localized in the subapical contact zone between cells. In *sac-1(ycx18)*-- or ARF-6(Q67L)--overexpressing animals, HMP-1-GFP mislocalized in lateral plasma membranes. Arrowheads indicate subapical labeling of HMP-1-GFP. Arrows indicate the abnormal labeling of HMP-1-GFP in lateral membranes. Percentages of defective HMP-1 labeling in 18 intestinal cells (total of six animals per each genotype) were quantified and plotted. Bars, 10 µm.](JCB_201711065_Fig4){#fig4}

The scaffold proteins JIP3 and JIP4, the mammalian homologues of *C. elegans* UNC-16, are considered to be Arf6 effectors ([@bib42]; [@bib58], [@bib59]). Our data indicate that SAC-1 negatively regulates endosomal PI(4,5)P2 in intestinal epithelia. A plausible explanation is that the ARF-6 interactor SAC-1 regulates ARF-6 activity through a negative feedback loop. If so, then we would expect to observe the overaccumulation of the ARF-6 putative effector UNC-16 in *sac-1* mutants. In wild-type animals, UNC-16-GFP labeled basolateral tubular and punctate structures in intestinal cells. As expected, in the absence of SAC-1, UNC-16-GFP concentrated in the cytosolic puncta ([Fig. 4, C and C](#fig4){ref-type="fig"}′), suggesting that ARF-6 activity is abnormally promoted.

Apical junctional protein HMP-1 mislocalizes in lateral membrane of *sac-1* mutant cells {#s10}
----------------------------------------------------------------------------------------

A recent study in sea urchin primary mesenchyme cells showed that constitutively active Arf6 induced mislocalization of junctional cadherin ([@bib89]). In *C. elegans*, apical junctions contain cadherin, HMP-1 (α-catenin), and HMP-2 (β-catenin; [@bib18]). To determine whether ARF-6 is also required for the proper localization of apical junctions in *C. elegans* epithelia, we examined the distribution of HMP-1 in vivo ([@bib18]; [@bib80]). Usually, HMP-1-GFP exclusively labels the subapical contact zone between cells ([@bib51]). In the presence of constitutively active ARF-6(Q67L), HMP-1-GFP unexpectedly appeared in punctate structures in lateral plasma membranes (72.2% defective; [Fig. 4, D and D](#fig4){ref-type="fig"}′), consistent with a role of ARF-6/Arf6 in mediating the recycling of apical junction proteins. Also, a similar mislocalization of HMP-1-GFP was observed in *sac-1(ycx18)* mutant animals (66.6% defective; [Fig. 4, D and D](#fig4){ref-type="fig"}′). Our data further indicate that ARF-6 activity is abnormally elevated in SAC-1--depleted cells.

SAC-1 interacts with ARF-6 GEF protein BRIS-1 {#s11}
---------------------------------------------

Thus far, our evidence suggests that SAC-1 plays a role in curbing ARF-6 activity in *C. elegans* intestines by a mechanism not yet determined. To explore the underlying mechanism, we first investigated whether CNT-1/ACAPs/ARF-6-GAP interacts with SAC-1 by GST pull-down. No significant interaction between GST-SAC-1 and HA-CNT-1 was recorded (Fig. S5 A). We then assayed the subcellular localization of previously reported Arf6/ARF-6 GEFs. Three ARF-6-GEF proteins are encoded in the genome of *C. elegans*, including cytohesin family protein GRP-1, EFA6 family protein EFA-6, and BRAG family protein BRIS-1 (Fig. S5 B). We developed transgenic animals that specifically express GFP fusion proteins of GRP-1, EFA-6, and BRIS-1 in intestinal cells. The subcellular localization of BRIS-1-GFP was affected by the loss of SAC-1. In particular, BRIS-1-GFP-labeled basolateral tubular meshwork was mostly absent, and GFP fluorescence signals appeared in overaccumulated puncta ([Fig. 5, A](#fig5){ref-type="fig"} and A′; ∼2.6-fold intensity increase). However, the distribution of GRP-1 within nuclei remained intact after depletion of SAC-1 (Fig. S5, C and C′). Also, SAC-1 deficiency only moderately disturbed the integrity of EFA-6-positive meshwork, whereas the overall intensity of EFA-6 labeling was not significantly affected (Fig. S5, D and D\'). Next, we performed colocalization assays to examine the colabeling of BRIS-1 with the early endosome marker mCherry-RAB-5 and the recycling endosome marker mCherry-RAB-10. In agreement with the localization changes of ARF-6, a remarkable overlap between BRIS-1 and RAB-5 in enlarged endosomes was observed in SAC-1--depleted cells ([Fig. 5, B and B](#fig5){ref-type="fig"}′), whereas the colocalization of BRIS-1 with RAB-10 in punctate structures was significantly reduced ([Fig. 5, B and B](#fig5){ref-type="fig"}′).

![**SAC domain mediates the interaction of SAC-1 with BRIS-1/ARF-6-GFE. (A and A′)** Compared with wild-type animals, loss of SAC-1 led to the disruption of basolateral tubular network labeled by GFP-BRIS-1, and GFP-BRIS-1 appeared in aggregates. Error bars represent SEM (*n* = 18 each). Asterisks indicate significant differences in the one-tailed Student's *t* test (\*\*\*, P \< 0.001). **(B and B′)** In *sac-1(RNAi)* animals, the overlap between GFP-BRIS-1 and mCherry-RAB-5 was enhanced. In *sac-1(RNAi)* animals, the colocalization between GFP-BRIS-1 and mCherry-RAB-10 was decreased. Arrowheads indicate positive overlap. Pearson's correlation coefficients for GFP and mCherry signals were calculated (*n* = 6 animals). Error bars represent SEM. \*\*\*, P \< 0.001. **(C)** Glutathione beads loaded with GST and GST-SAC-1 were incubated with HA-tagged BRIS-1, EFA-6, and GRP-1, respectively. Eluted proteins were separated on the SDS-PAGE gel and analyzed by Western blotting using anti-HA antibody. Input lanes contain in vitro expressed HA-tagged proteins in the binding assays (5%). **(D and D′)** GFP-SAC-1 overlapped with mCherry-BRIS-1 significantly in intracellular puncta (Pearson's coefficient, ∼75.8%). Pearson's correlation coefficients for GFP and mCherry signals were calculated (*n* = 6 animals). **(E)** The fragment (aa 1--537) containing the SAC domain can efficiently associate with BRIS-1. Similarly, the SAC domain with catalytic core mutations (D409N or G460V&R498H) maintains the capability of binding to BRIS-1. **(F and F′)** The labeling intensity of Tb^R332H^-GFP in the basolateral endosomes was significantly promoted in *sac-1(ycx18)* mutants. In mCherry-SAC-1(D409N)--overexpressing intestinal cells, Tb^R332H^-GFP labeling in puncta and tubules decreased. In mCherry-SAC-1(G460V&R498H)--overexpressing cells, Tb^R332H^-GFP labeling in puncta and tubules was reduced. Error bars represent SEM (*n* = 18 each), and asterisks indicate the significant differences in the one-tailed Student's *t* test (\*, P \< 0.05; \*\*\*, P \< 0.001). **(G and G′)** The labeling intensity of hTAC-GFP was significantly increased in *sac-1(ycx18)* mutants. In mCherry-SAC-1(D409N)--overexpressing intestinal cells, hTAC-GFP labeling was also increased. In mCherry-SAC-1(G460V&R498H)--overexpressing cells, hTAC-GFP labeling was increased. Error bars represent SEM (*n* = 18 each), and asterisks indicate the significant differences in the one-tailed Student's *t* test (\*\*, P \< 0.01; \*\*\*, P \< 0.001). Bars, 10 µm.](JCB_201711065_Fig5){#fig5}

To better assess the correlation of SAC-1 with BRIS-1, we performed GST pull-down assays to examine the interaction of GST-SAC-1 with HA-tagged GRP-1, EFA-6, and BRIS-1, respectively. As shown in [Fig. 5 C](#fig5){ref-type="fig"}, SAC-1 displayed a robust protein--protein interaction with BRIS-1, whereas no significant binding existed between SAC-1 and GRP-1 or EFA-6 ([Fig. 5 C](#fig5){ref-type="fig"}). Coimmunoprecipitation experiments were performed to validate the interaction between SAC-1 and BRIS-1 (Fig. S1 C). Consistently, there was substantial colocalization between GFP-SAC-1 and mCherry-BRIS-1 in intracellular puncta ([Fig. 5, D and D](#fig5){ref-type="fig"}′; Pearson's correlation coefficient, ∼75.8%).

Catalytic activity of SAC domain is not implicated in the interaction with BRIS-1 {#s12}
---------------------------------------------------------------------------------

Previous studies showed that SAC domains are involved in the regulation of protein interactions ([@bib74]). To determine whether the SAC domain mediates the binding of SAC-1 with BRIS-1, we selected the fragment (aa 1--537) containing the N-terminal SAC domain as bait to examine the interaction with BRIS-1. We observed that the SAC domain is sufficient to mediate the interaction with BRIS-1 ([Fig. 5 E](#fig5){ref-type="fig"}). Next, we used the SAC domain with catalytic core mutations for binding testing ([@bib44]; [@bib53]). However, the association of BRIS-1 with the SAC domain was not affected by point mutations D409N or G460V&R498H ([Fig. 5 E](#fig5){ref-type="fig"} and Table S2). Therefore, our biochemical experiments described above indicate that the SAC domain serves as the interface for binding with BRIS-1, but phosphatase activity seems to be unrelated to this interaction.

To determine whether the PI(4,5)P2 and hTAC phenotypes are correlated with the catalytic activity of SAC-1, we examined the subcellular localization of the Tb^R332H^-GFP and hTAC-GFP in SAC-1--depleted cells coexpressing the CRISPR/Cas9 editing--resistant forms of SAC-1 with catalytic core mutations ([Fig. 5, F--G](#fig5){ref-type="fig"}′). Notably, Tb^R332H^-GFP labeling defects were significantly complemented by the transgenic expression of SAC-1(D409N) and SAC-1(G460V&R498H) ([Fig. 5, F and F](#fig5){ref-type="fig"}′). The consistent inactivation of ARF-6 leads to the decrease in PI(4,5)P2 levels and the overaccumulation of hTAC-GFP ([@bib83]). Accordingly, hTAC-GFP cytosolic accumulation was observed in the animals overexpressing SAC-1(D409N) or SAC-1(G460V&R498H) ([Fig. 5, G and G](#fig5){ref-type="fig"}′). Together these results suggest that the functional role of SAC-1 in PI(4,5)P2 abundance modulation and the recycling transport is independent of the phosphoinositide phosphatase activity of SAC-1, thus rationalizing the interaction of BRIS-1 with the SAC domain harboring point mutations D409N or G460V&R498H.

SAC-1 competes with ARF-6(T27N) for interaction with BRIS-1/ARF-GEF {#s13}
-------------------------------------------------------------------

Thus far, our experiments demonstrated that SAC-1 interacts with ARF-6-GEF protein BRIS-1 and functions to restrain ARF-6 activity. Furthermore, we observed that the Sec7 domain of BRIS-1 mediates the interaction of BRIS-1 with SAC-1 (Fig. S5 E). It is worth noting that Arf small GTPases preferentially associate with the Sec7 domain of their GEF proteins, as previously described ([@bib72]). This evidence raises the possibility that SAC-1 competes with ARF-6(GDP) for the Sec7 domain of BRIS-1, thereby interfering with the interaction of BRIS-1 and ARF-6(GDP). To test this proposed mechanism, we first examined whether the presence of SAC-1 affects the affinity of the BRIS-1-Sec7 domain to the GDP-bound mutant form ARF-6(T27N). In the absence of SAC-1, there was a certain level of binding between GST-Sec7 and HA-ARF-6(T27N) ([Fig. 6, A](#fig6){ref-type="fig"} and A′). However, the affinity between the Sec7 domain and ARF-6(T27N) was significantly reduced after adding HA-SAC-1 to the reaction ([Fig. 6, A--A](#fig6){ref-type="fig"}″). Specifically, HA-SAC-1 outcompeted HA-ARF-6(T27N) for binding to GST-Sec7 in a concentration-dependent manner. The presence of increasing concentrations of HA-SAC-1 gradually weakened the GST-Sec7:HA-ARF-6(T27N) interaction. Our results support the SAC-1:BRIS-1:ARF-6(GDP) competition model, which predicts that SAC-1 antagonizes BRIS-1 during the activation of ARF-6.

![**SAC-1 competes with ARF-6(T27N) for binding to the Sec7 domain of BRIS-1. (A--A″)** SAC-1 outcompeted ARF-6(T27N) for interaction with the Sec7 domain in a concentration-dependent manner, as determined by GST pull-down. Three independent experiments are represented in the histogram, error bars represent SEM (*n* = 3 each), and P values are indicated above. **(B and B′)** In wild-type animals, mCherry-BRIS-1 mainly labeled basolateral tubules and puncta and partially colocalized with ARF-6-GFP (Pearson's coefficient, ∼72.4%). In *sac-1(ycx18)* mutants, mCherry-BRIS-1 and ARF-6-GFP were concentrated in the intracellular aggregates, and their colocalization level was substantially promoted (Pearson's coefficient, ∼85.4%). Arrowheads indicate positive overlap. Pearson's correlation coefficients for GFP and mCherry signals were calculated (*n* = 6 animals). Asterisks indicate significant differences in the one-tailed Student's *t* test (\*\*, P \< 0.01). **(C and C′)** Compared with wild-type animals, the labeling intensity of Tb^R332H^-GFP in the basolateral endosomes was grossly increased in *sac-1(ycx18)* mutants. Furthermore, RNAi-mediated knockdown of BRIS-1 significantly eased the intensity of Tb^R332H^-GFP in *sac-1* mutants. Error bars represent SEM (*n* = 18 each), and asterisks indicate significant differences in the one-tailed Student's *t* test (\*\*\*, P \< 0.001). **(D and D′)** RNAi-mediated knockdown of BRIS-1 greatly reduced the accretion of hTAC-GFP in *sac-1* mutants. Error bars represent SEM (*n* = 18 each), and asterisks indicate the significant differences in the one-tailed Student's *t* test (\*\*\*, P \< 0.001). Bars, 10 µm.](JCB_201711065_Fig6){#fig6}

mCherry-BRIS-1 predominantly labeled the basolateral tubular and punctate endosomes and colocalized well with ARF-6-GFP ([Fig. 6, B and B](#fig6){ref-type="fig"}′; Pearson's correlation coefficient, ∼72.4%). Consistent with the competition model, mCherry-BRIS-1 and ARF-6-GFP were concentrated in enlarged structures, and their colocalization was substantially promoted in *sac-1(ycx18)* mutants ([Fig. 6, B and B](#fig6){ref-type="fig"}′; Pearson's correlation coefficient, ∼85.4%). To investigate the functional conservation of SCAM1L, the mammalian homologue of *C. elegans* SAC-1, we examined the colabeling between Arf6 and its GEF protein, BRAG2, in HeLa cells. Arf6-mCherry and GFP-BRAG2 colocalize well in the intracellular puncta in control cells (Fig. S5, F--G\'). In the absence of SCAM1L, the overlap between Arf6 and BRAG2 was remarkably boosted in the enlarged structures (Fig. S5, G and G′), suggesting that loss of SCAM1L led to an excessive association of BRAG2 with Arf6 in endosomes. Furthermore, after RNAi-mediated knockdown of BRIS-1, we observed a significant reversal of Tb^R332H^-GFP intensity in SAC-1--depleted cells ([Fig. 6, C and C](#fig6){ref-type="fig"}′), suggesting that BRIS-1 mediates SAC-1--deficiency induced PI(4,5)P2 buildup. Consistently, the overaccumulation phenotype of hTAC-GFP was notably reduced in *sac-1(ycx18);bris-1(RNAi)* animals ([Fig. 6, D and D](#fig6){ref-type="fig"}′). Moreover, we observed the remarkable reduction of UNC-16-GFP accumulation in the cytosol (Fig. S5, J and J′). In summary, our experiments identify SAC-1 as a novel ARF-6 interactor that mediates negative feedback regulation of ARF-6 in *C. elegans* intestinal cells, likely with the involvement of the ARF-6 GEF protein BRIS-1.

Discussion {#s14}
==========

Arf6 is implicated in the recycling regulation of clathrin-independent cargo, and cargo sorting after endocytosis requires timely shutdown of Arf6 activity ([@bib23]). However, Arf6 needs to be reactivated for proper endocytic recycling. Constitutive inactivation of ARF-6 leads to irregular hTAC-GFP recycling transport ([@bib83]). The on-and-off activity of Arf6 is regulated by GEFs and GAPs. To better characterize the regulatory mechanism of ARF-6, we identified SAC-1 as a previously unrecognized ARF-6 interactor in *C. elegans*. In *sac-1* mutant animals, ARF-6 activity was significantly boosted. The presence of SAC-1 restrained the interaction of ARF-6(T27N) with BRIS-1 in a concentration-dependent manner, suggesting that SAC-1 has an antagonistic effect on ARF-6(GTP) levels via a feedback loop.

Sac1p/hSAC1 contains an N-terminal SAC domain and two C-terminal transmembrane helices ([@bib46]; [@bib36]). Previous studies showed that Sac1p/hSAC1 localizes predominantly to the ER and Golgi ([@bib45]; [@bib74]; [@bib4]; [@bib2]; [@bib16]). The distribution of hSAC1 in the Golgi is determined by the first transmembrane helix, and the N-terminal cytoplasmic region contributes to localization ([@bib92]). The Golgi residence of Arabidopsis AtSAC1 also depends on the C-terminus, and the AtSAC1 truncation without the C-terminal segment results in abnormal distribution in the cytoplasm ([@bib98]). Consistently, *C. elegans* SAC-1 localizes to the trans-Golgi network and ER in our study. Furthermore, we found that SAC-1 appears on endosomes near the basolateral plasma membrane, and the endosomal residence of SAC-1 relies on ARF-6. Previous studies indicate that there is direct cargo flow between the Golgi and recycling endosomes ([@bib1]), and the pool of PI(4)P in the Golgi contributes to the homeostasis of PI(4,5)P2 in the plasma membrane ([@bib21]). Similar to the shuttling of hSAC1 between the ER and plasma membrane via dynamic changes in ER-PM junctions ([@bib22]), SAC-1 intracellular localization in intestinal cells suggests that SAC-1 is probably also involved in the regulation of PIP homeostasis between the Golgi and sorting endosomes. Validating this possibility would require further experimentation.

Accumulating evidence indicates that Sac1p and its homologues could efficiently regulate intracellular PI(3)P, PI(4)P, and PI(3,5)P2 levels. Meanwhile, hSAC1 also manipulates PI(4,5)P2 levels indirectly by various mechanisms. For example, a recent study showed that hSAC1 localizes at discrete ER-PM junctions, where it limits the production of PI(4,5)P2 via limiting PI(4)P pool in the plasma membrane ([@bib22]). There is another mechanism by which hSAC1 regulates PI(4,5)P2 level indirectly in tsA-201 cells ([@bib21]). The Golgi PI(4)P pool is tightly correlated with the PI(4,5)P2 levels in the plasma membrane, and hSAC1 may indirectly influence PI(4,5)P2 in the plasma membrane by regulating PI(4)P in the Golgi. Our experiments demonstrate that SAC-1, as an ARF-6 interactor, can confine ARF-6 activity and influence the level of endosomal PI(4,5)P2. It is likely that these distinct PI(4,5)P2 regulatory mechanisms of hSAC1/SAC-1 have their characteristic implication in terminally differentiated cell types. However, without extensive experimental studies, we cannot rule out the possibility that these mechanisms coexist in the same cellular context. In addition to hSAC1, mammalian SAC2 was also found in recycling endosomes in the mouse neuroblastoma N2A cells ([@bib37]). SAC2 is a phosphoinositide 4-phosphatase that hydrolyzes PI(4)P. The overexpression of the catalytically inactive mutant of SAC2 disrupted the recycling transport of TfR ([@bib37]). However, we failed to observe abnormal hTAC-GFP distribution in *sac-2* mutants. PI(4)P biosensor GFP-P4M--labeled structures were not significantly affected in *sac-1* mutant cells. These findings suggest that the regulatory role of SAC-1 in basolateral recycling is not directly associated with PI(4)P modulation. It is worth noting that basolateral secretory cargo NPY-GFP--labeled meshwork was intact in *sac-1* mutants. However, similar to *rab-8* mutant animals, apical secretory cargo PGP-1-GFP severely overaccumulated in the cytoplasm of SAC-1--depleted cells. Our data suggest that SAC-1 is involved in promoting apical secretory delivery without affecting the basolateral counterpart in the intestinal epithelia of *C. elegans*. Surprisingly, the morphology or distribution of AMAN-2-GFP--labeled TGN or SP12-GFP--labeled ER was not affected by the loss of SAC-1. These results indicate that the apical and basolateral secretory transport has distinct regulatory mechanisms in intestinal epithelia, whereas SAC-1 is only involved in the apical secretory process. Additionally, the disturbance of the SAC-1--mediated secretory delivery is not directly associated with the morphological abnormality in the Golgi and ER, suggesting that the phenotype is caused by functionality damage. Sac1p was reported to play a crucial role in mediating ATP transport into the ER ([@bib55]). Another plausible explanation is the regulatory redundancy in basolateral secretory transport. SAC domains in yeast Inp52p and Inp53, and mammalian and *Drosophila* synaptojanin also maintain hydrolyzing specificity toward PI(3)P, PI(4)P, and PI(3,5)P2 ([@bib31]; [@bib39]; [@bib63]; [@bib16]; [@bib22]; [@bib91]). *C. elegans* OCRL-1, the homologue of Inp52p and Inp53p, was found to be expressed in the intestinal cells ([@bib88]). Similarly, UNC-26/synaptojanin expression was found in the intestine ([@bib56]; [@bib40]). These SAC domain proteins may compensate for the lack of SAC-1 during basolateral secretory transport.

Arf6-GEFs can be regulated by distinct mechanisms in diverse cellular processes ([@bib35]). We found that the subcellular localization of BRIS-1 was disrupted in the absence of SAC-1, whereas the distribution of GRP-1 and EFA-6 remained virtually unchanged. Consistently, SAC-1 had no significant physical interaction with GRP-1 or EFA-6. In intestinal epithelia, the interaction between SAC-1 and BRIS-1 effectively governs the activity of ARF-6 and the endosomal PI(4,5)P2. Therefore, we speculate that the precise spatial and/or temporal control of Arf6-GEFs activity determines the working specificity of Arf6, and this functional commitment is likely to be established by the dedicated regulators of Arf6-GEFs in distinct biological processes. A recent study in human retinal microvascular endothelial cells demonstrated that various GEFs were sequentially used to activate Arf6 to coordinate VEGFR2 trafficking ([@bib100]). Arf6-GEF ARNO activates Arf6 and promotes VEGFR2 internalization, whereas Arf6-GEF GEP100 acts later to activate Arf6 to encourage VEGFR2 recycling. Although the exact mechanism of sequential usage of Arf6-GEFs in VEGFR2 trafficking is still unknown, the involvement of highly specific Arf6-GEF regulation is emerging as a common theme in the mechanisms of vesicle trafficking.

In the current study, we observed that the absence of ARF-6 resulted in the significantly reduced localization of GFP-SAC-1 in basolateral puncta. SAC-1 is a transmembrane protein, and presumably, there is no process of SAC-1 recruitment from the cytoplasm to the endosome. One explanation for our results is that ARF-6 is required for clustering SAC-1 from other connected membranous organelles to the sorting endosomes. To this end, we performed rescue experiments by coexpressing ARF-6(Q67L)-mCherry or ARF-6(T27N)-mCherry in *arf-6(tm1447)*;GFP-SAC-1 animals, respectively. The results showed that the expression of ARF-6(Q67L) significantly recovered the puncta labeling GFP-SAC-1, whereas the expression of ARF-6(T27N) failed to restore the endosomal localization of GFP-SAC-1, suggesting that the interaction between SAC-1 and ARF-6(GTP) predominantly determines the endosomal positioning of SAC-1. Additionally, we found that the presence of HA-SAC-1 significantly reduced the binding of GST-BRIS-1(Sec7 domain) to HA-ARF-6(T27N), suggestive that SAC-1 could outcompete ARF-6(GDP) to occupy BRIS-1. It should be noted that unlike Arf1(GDP), Arf6(GDP) is mostly retained on membranes ([@bib9]; [@bib87]; [@bib23]). Thus, we propose that the interaction of ARF-6(GDP) with SAC-1 on the membrane does not administrate the endosomal localization of SAC-1 ([Fig. 1 C](#fig1){ref-type="fig"}) but instead maintains the proximity of SAC-1 on sorting endosomes to facilitate the competition with ARF-6(GDP) itself. This speculation is corroborated by the additional experiments (Fig. S5, H and I). The addition of HA-SAC-1 failed to affect the interaction between ARF-6(T27N) and another ARF-6 GEF protein, EFA-6 (Fig. S5 H), suggesting that the interaction between SAC-1 and BRIS-1/GEF, rather than the interaction between SAC-1 and ARF-6(T27N), plays a prominent role in the competition for binding to BRIS-1. Moreover, the interaction between the ARF-6 GAP protein GST-CNT-1 and HA-ARF-6(Q67L) was not affected by the presence of HA-SAC-1 (Fig. S5 I), implying that the interaction between SAC-1 and ARF-6(Q67L) is not involved in the competition for BRIS-1. Taken together, our results suggested that ARF-6(GTP) is primarily responsible for clustering SAC-1 to sorting endosomes, whereas the interaction of ARF-6(GDP) with SAC-1 could be involved in the maintenance of SAC-1 endosomal proximity, allowing SAC-1 to compete with ARF-6(GDP) for the binding interface on the GEF protein BRIS-1.

Materials and methods {#s15}
=====================

General methods and strains {#s16}
---------------------------

The strains were originated from Bristol strain N2. Culturing and genetic manipulation of the animals were performed according to the standard procedure ([@bib6]). All strains were grown on NGM plates at 20°C, with *Escherichia coli* strain OP50 as the source of food. A complete list of strains can be found in Table S1.

RNAi {#s17}
----

RNAi-mediated interference is based on standard feeding protocol ([@bib90]). The feeding constructs used in this study were either from the Ahringer library ([@bib43]) or prepared by subcloning cDNA fragments into the RNAi vector L4440 ([@bib90]). In most of our experiments, synchronized L1 stage animals were cultured for 72 h and scored as adults.

Antibodies {#s18}
----------

The antibodies used in the current study are listed below: rabbit anti--actin polyclonal antibody (sc-1616-R; Santa Cruz Biotechnologies), rabbit anti--HA monoclonal antibody (C29F4; Cell Signaling Technology), rabbit anti--GST monoclonal antibody (91G1; Cell Signaling Technology), rabbit anti--mCherry polyclonal antibody (ab167453; Abcam), rabbit anti--GFP polyclonal antibody--chromatin immunoprecipitation grade (ab290; Abcam), mouse anti--P(4,5)P2 monoclonal antibody (Z-P045; Echelon Biosciences), and mouse anti--PIP~n~ monoclonal antibody (Z-P999; Echelon Biosciences).

Somatic CRISPR/Cas9 mutant strains {#s19}
----------------------------------

CRISPR/Cas9 plasmids were prepared following the previously described protocol ([@bib81]; [@bib48]). The somatic CRISPR/Cas9 expression plasmids were prepared by replacing the *eft-3* promoter in pDD162 (47549; Addgene) with the *C. elegans* intestine-specific promoter P*vha-6* via overlapping PCR using Phusion high-fidelity DNA polymerase (Thermo Scientific). CRISPR design tool (<http://crispr.mit.edu>) was deployed to identify the targets. Three *sac-1* target sequences were chosen in this study (5′-AGCCAGCGAACGTTTCATATGG-3′, 5′-CAGCAAGCTGGTCATCTGTTGG-3′, and 5′-GAACAATTAAACTAGTCTCAGG-3′). CRISPR/Cas9 plasmids were transformed into DH5α competent cells. The clones were validated to include the target sequences via sequencing. CRISPR/Cas9 plasmids transgenic animals were developed by microinjection of plasmids at 50 ng/µl and a selection marker P*odr-1::gfp* into the N~2~ hermaphrodites germline ([@bib99]).

Cell cultures and transfection {#s20}
------------------------------

HeLa cells were cultured in DMEM supplemented with 10% heat-inactivated fetal bovine serum, 100 U/ml penicillin, and 100 U/ml streptomycin. Exponentially growing cells were trypsinized. Solutions with 50,000 cells/ml were prepared in 90% medium (no phenol red or antibiotics) with 10% vol/vol serum. Cells were incubated at 37°C for 2 h before siRNA transfection. 12 µl X-tremeGENE siRNA Transfection Reagent (Sigma), 2 µg siRNA nontargeting control or siRNA plasmid, 2 µg GFP-BRAG2 plasmid, and 2 µg Arf6-mCherry plasmid were added into 100 µl OPTI-MEM I (Gibco). The transfection mix was incubated at room temperature for 5 min and then mixed for 20 min 24 h after transfection, and cells were fixed with 5% paraformaldehyde for 5 min at room temperature. Human SCAM1L siRNA oligonucleotide was synthesized with the sequence 5′-GAGATGGGATCGACTAAGT-3′ (Ribobio Inc.).

GST pull-down assay and Western blotting {#s21}
----------------------------------------

rab-5(Q78L), rab-7(Q67L), rab-8(Q67L), rab-10(Q68L), rab-11.1(Q70L), arf-6(Q67L), arf-6(T27N), sac-1, sac-1(1-537aa), sac-1(1-537aa,D409N), sac-1(1-537aa,G460V&R498H), sac-1(Δ133-507aa), bris-1, bris-1(220-422aa), efa-6, grp-1, and cnt-1 cDNAs were transferred into a modified vector pcDNA3.1(+) (Invitrogen) with a 2xHA epitope tag and Gateway cassette (Invitrogen) for in vitro transcription and translation. sac-1, bris-1, and bris-1(220-422aa) PCR products were introduced into pGEX-2T vector (GE Healthcare Life Sciences) with a Gateway cassette. The N-terminally HA-tagged proteins were synthesized using the TNT-coupled transcription-translation system (Promega). GST-only, GST-SAC-1, GST-BRIS-1, and GST-BRIS-1(220--422 aa) fusion proteins were expressed in the ArcticExpress strain of *E. coli* (Stratagene). Bacterial pellets were lysed in 50 ml lysis buffer (50 mM Hepes, pH 7.5, 400 mM NaCl, 1 mM DTT, and 1 mM PMSF) with Complete Protease Inhibitor Mixture Tablets (Sigma). Extracts were cleared by centrifugation, and supernatants were collected and incubated with glutathione Sepharose 4B beads (GE Healthcare Life Sciences) at 4°C overnight. Beads were washed six times with cold STET buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, and 0.1% vol/vol Tween-20). In vitro--synthesized HA-tagged protein (15 µl TNT mix diluted in 500 µl STET) was added to the beads and allowed to bind at 4°C overnight. After six additional washes in STET, the proteins were eluted by boiling in 30 µl 2×SDS-PAGE sample buffers. Eluted proteins were separated on SDS-PAGE (12% wt/vol polyacrylamide) and blotted onto nitrocellulose. After blocking with 5% milk and washing with TBS-T buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, and 0.05% vol/vol Tween-20), the blot was probed with the anti--HA antibody and then stripped and reprobed with the anti--GST antibody.

Plasmid construction and transgenic strains {#s22}
-------------------------------------------

For *sac-1(ycx18)* mutant rescue assay, corresponding sgRNA resistant plasmids were prepared. We introduced silent mutations in the codon of each target sequence (5′-GGCTTCAGAGAGGTTTATCTGG-3′, 5′-CTGCCAATTGATCGTCAGTAGG-3′, and 5′-GTACTATCAAGTTGGTAAGTGG-3′). To construct GFP or mCherry fusion transgenes expressed in *C. elegans* intestine, previously described *vha-6* promoter-driven vectors with a Gateway cassette inserted upstream or downstream of the GFP or mCherry coding region were used. The sequences of *sac-1*, *bris-1*, *efa-6, grp-1*, *Tubby-PH(R332H)* ([@bib70]; [@bib33]), *2xML1N* (reporter of PI(3,5)P2), and *P4M* (reporter of PI4P) were cloned in-frame into entry vector pDONR221 by BP reaction, and then transferred into intestinal expression vectors by LR reaction to generate fusion plasmids ([@bib11]). Low-copy integrated transgenic lines were obtained using the microparticle bombardment method ([@bib69]). Additional transgenic strains were obtained using standard microinjection techniques.

Whole-worm immunoprecipitation {#s23}
------------------------------

Adult animals were collected and washed with M9 buffer (9-cm plates × 10). The worm pellet was lysed in ice-cold lysis buffer (25 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1 mM PMSF, 1 mM Na~3~VO~4~, 1 µg/ml Pepstatin-A, and 10 mM NaF) containing protease inhibitor cocktail (Sigma). The lysates were incubated for 30 min at 4°C and centrifugated at 13,000 *g* for 30 min. The supernatant was incubated with 80 µl Protein A+G Agarose (Beyotime) for 1 h at 4°C to preclear nonspecific bead--protein interactions. 2 µl anti--GFP antibody (ab290) was added into precleared supernatant and incubated overnight at 4°C, followed by incubation with 80 µl Protein A+G Agarose for 4 h at 4°C. Precipitates were washed five times (10 min each) with lysis buffer and subjected to immunoblotting using anti--actin, anti--mCherry, and anti--GFP antibodies.

PIP immunostaining {#s24}
------------------

Animal dissection was performed as previously described ([@bib30]). Dissected intestines were fixed in 4% paraformaldehyde (Beyotime) in TBS for 20 min at room temperature, and washed three times (10 min each) in TBS, followed by treatment with 0.5% Saponin (S-7900; Sigma) in TBS for 15 min at room temperature. The specimens were then washed three times (10 min each) in TBS and blocked with 10% goat serum in TBS overnight at 4°C. Whole-mount staining using mouse anti-PIP antibody (Echelon Biosciences) diluted in TBS was performed for 1 h at 37°C. The specimens were then washed three times (10 min each) in TBS/goat serum 1%. Secondary antibodies conjugated to Alexa Fluor 488 (Thermo Fisher Scientific) were used at a dilution of 1:2,000 in TBS for 30 min at 37°C. Observations were performed with a 100×, 1.2-NA oil-immersion objective len at room temperature using a C2 laser scanning confocal microscope (Nikon).

Microscopy and imaging analysis {#s25}
-------------------------------

Live worms were mounted onto 2% agarose pads with 100 mM levamisole. Monofluorescence and multiwavelength fluorescence images were acquired at 20°C using a C2 laser scanning confocal microscope equipped with a 100× 1.2-NA oil-immersion objective and NIS-Elements AR 4.40.00 software. Z-series of optical sections were acquired using a 0.5 µm step size.

Monofluorescence images were analyzed by Metamorph software version 7.8.0.0 (Universal Imaging). The "Integrated Morphometry Analysis" function of Metamorph software was employed to measure the fluorescent intensity that is significantly brighter than the background (total intensity), fluorescence area (total area), and puncta number (structure count) within unit regions. From a total of six animals of each genotype, "total intensity," "structure count," and "total area" were sampled in three randomly selected unit regions of each animal defined by a 100 × 100 (pixel^2^) box positioned at random (*n* = 18 each). In the current study, total area was used to compare tubularity, as the endosomal tubule covers more area than when the tubular network collapses into puncta. Quantification of colocalization images was performed using the open source Fiji (ImageJ) software ([@bib78]). Pearson's correlation coefficients for GFP and mCherry signals were calculated, and six animals for each genotype were assessed.

Statistical analysis {#s26}
--------------------

Statistical analyses in the current study were performed using Prism software version 5.01 (GraphPad Software).

Online supplemental material {#s27}
----------------------------

Fig. S1 demonstrates that the endosomal localization of mCherry-SAC-1 is impaired in *arf-6(RNAi)* animals. However, the Golgi and ER labeling of mCherry-SAC-1 is intact in *arf-6(RNAi)* animals. Fig. S2 shows that the transport of basolateral secretory cargo NPY-GFP is not affected in *sac-1(ycx18)* animals. In contrast, apical secretory cargo protein PGP-1-GFP accumulates in *sac-1(ycx18)* mutants. Fig. S3 shows that the level of PI(4,5)P2 in basolateral endosomes is promoted in *sac-1(RNAi)* animals. Also, the level of total PIPs increases moderately in *sac-1(RNAi)* animals. Fig. S4 shows that the recycling marker GFP-RME-1 accumulates in RAB-5--positive endosomes in SAC-1-depleted cells. Fig. S5 shows that loss of SCAM1L boosts the colocalization between GFP-BRAG2 and Arf6-mCherry. Moreover, SAC-1 fails to outcompete ARF-6(T27N) for interaction with EFA-6. Table S1 lists transgenic and mutant strains. Table S2 shows the alignment of *C. elegans* SAC-1 and the closely related homologues in human and yeast.
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